ArticlebioRxiv : the preprint server for biology2025
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies.
Sander Frank et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.